Skip to main content
Figure 1 | Thrombosis Journal

Figure 1

From: Meta regression analysis to indirectly compare dalteparin to enoxaparin for the prevention of venous thromboembolic events following total hip replacement

Figure 1

Meta analysis on the relative risk of VTEs in placebo-controlled trials evaluating enoxaparin or dalteparin in THR patients. The pooled VTE relative risk was significantly different between pharmacotherapy (dalteparin or enoxaparin) vs. placebo; p < 0.001. Test for heterogeneity: Chi2 = 13.9, df = 10, p = 0.18, I2 = 28.1%

Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us